Gene therapy trial aims to halt bulging eyes in thyroid disease
Disease control
Not yet recruiting
This early-stage study is testing a new gene therapy called VV-14305 for people with moderate to severe thyroid eye disease. The therapy is given as an injection near the eye. Researchers will check if it's safe and if it can reduce eye bulging and other symptoms compared to a sh…
Phase: PHASE1, PHASE2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC